Rapidly Recover
Medical Radioisotopes
The supply of medical radionuclides is extremely constrained making it essential to preserve these scarce resources by efficiently recovering them. RadSep’s simple, highly selective technology rapidly recovers radioisotopes at very high levels (99.9+%) and purities (up to 99.99%).
Revolutionary Radioisotope
Purification Technology
RadSep offers Molecular Recognition Technology™ (MRT™) flowsheets and resins to rapidly recover and purify medical radioisotopes from various sources including brines, mining streams and nuclear waste. Reusable MRT™ resins can selectively separate individual radioisotopes at up to 99.99% purity and 99.9+% recovery.
Examples of medically important radioisotopes that can be purified with MRT™ are listed below:
Custom Chelating Agents
for Radioisotopes
To incorporate a radioisotope into a radiopharmaceutical that targets cancer cells, a molecule known as a chelating agent must bind to the correct radioisotope and keep it connected to the targeting molecule that recognizes cancer cells. These chelating agents must:
Bind the radioisotope selectively
to ensure purity and therefore
safety of the drug
Bind the radioisotope strongly to prevent it from
being released and damaging healthy cells
elsewhere in the body
RadSep has the capability to develop and manufacture chelating agents that are more stable and effective in vivo than common chelators such as DOTA, DOTEM and TCMC.
Advantages of Molecular
Recognition Technology™ (MRT™)
RadSep offers proprietary flowsheets and Molecular Recognition Technology™ (MRT™) resins with:
- High selectivity
- Fast throughput, rapid kinetics
- Superior chemical and radiolytic stability, resulting in multiple recycles and minimal waste
- Simple, single-step processes
- Up to 99.99% purity and 99.9+% recovery yield
- High loading capacities
- Benign reagents
- Small footprints
Latest News
October 3, 2024
June 6, 2024
